Log In
Print this Print this

TLR8 agonist

  Manage Alerts
Collapse Summary General Information
Company Idera Pharmaceuticals Inc.
DescriptionStabilized immune modulatory RNA that agonizes toll-like receptor 8 (TLR8)
Molecular Target Toll-like receptor 8 (TLR8)
Mechanism of ActionToll-like receptor 8 (TLR8) agonist
Therapeutic Modality 
Latest Stage of DevelopmentDiscovery
Standard IndicationAdjuvant
Indication DetailsVaccine adjuvant to treat and prevent cancer, infectious diseases and Alzheimer's disease (AD)
Regulatory Designation
PartnerMerck & Co. Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today